Ian W. Malone
Directeur/Membre du Conseil chez N-able Technologies, Inc.
Profil
Mr. Ian W.
Malone is Secretary at BluMetric Environmental, Inc. and Independent Director at PharmaGap, Inc. He is on the Board of Directors at PharmaGap, Inc. and N-able Technologies, Inc.
Mr. Malone was previously employed as CFO, Secretary & Head-Investor Relations by Seprotech Systems, Inc., Chief Financial Officer by Jennerex Biotherapeutics, Inc., Chief Financial Officer by Millenium Biologix Corp., and Chief Financial Officer by World Heart Corp.
He also served on the board at Liponex, Inc.
He received his undergraduate degree from the University of Strathclyde.
Postes actifs de Ian W. Malone
| Sociétés | Poste | Début |
|---|---|---|
N-able Technologies, Inc.
 N-able Technologies, Inc. Information Technology ServicesTechnology Services N-able Technologies, Inc. provides information technology services for managed service providers. It provides network monitoring and remote systems management software. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Directeur/Membre du Conseil | 09/05/2011 |
Anciens postes connus de Ian W. Malone
| Sociétés | Poste | Fin |
|---|---|---|
| BLUMETRIC ENVIRONMENTAL INC. | Directeur Financier/CFO | 31/01/2015 |
Seprotech Systems, Inc.
 Seprotech Systems, Inc. Environmental ServicesIndustrial Services Seprotech Systems, Inc. provides engineered water and wastewater treatment solutions to the municipal/land development, resource sector and military market place, including Reverse Osmosis water purification systems, ROTORDISK biological sewage treatment package plants and CrystalBlue membrane-based water recycling systems. The company was founded on September 6, 1985 and is headquartered in Ottawa, Canada. | Directeur Financier/CFO | 08/11/2012 |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Directeur Financier/CFO | 01/01/2010 |
| Liponex, Inc. | Directeur/Membre du Conseil | 03/07/2008 |
PharmaGap, Inc.
 PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Directeur/Membre du Conseil | - |
Formation de Ian W. Malone
| University of Strathclyde | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BLUMETRIC ENVIRONMENTAL INC. | Industrial Services |
| Entreprise privées | 7 |
|---|---|
Millenium Biologix Corp.
 Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Health Technology |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
World Heart Corp.
 World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Commercial Services |
| Liponex, Inc. | Health Technology |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Health Technology |
Seprotech Systems, Inc.
Seprotech Systems, Inc. Environmental ServicesIndustrial Services Seprotech Systems, Inc. provides engineered water and wastewater treatment solutions to the municipal/land development, resource sector and military market place, including Reverse Osmosis water purification systems, ROTORDISK biological sewage treatment package plants and CrystalBlue membrane-based water recycling systems. The company was founded on September 6, 1985 and is headquartered in Ottawa, Canada. | Industrial Services |
N-able Technologies, Inc.
N-able Technologies, Inc. Information Technology ServicesTechnology Services N-able Technologies, Inc. provides information technology services for managed service providers. It provides network monitoring and remote systems management software. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Technology Services |
